Latest Health And Wellness News

Page 1 of 10
Nuchev lifted FY26 revenue 12% to A$25.7 million, but a wider loss, weaker margins and heavier cash use have left the wellness group dependent on shareholder-backed funding. Post-year-end drawdowns reduced its available working-capital headroom to A$750,000.
Victor Sage
Victor Sage
20 Nov 2026
Clorox delivered a sharp first-quarter rebound, helped by the GOJO acquisition and an easier comparison after last year’s ERP-related inventory drawdown. But rising commodity, manufacturing and logistics costs have pushed its full-year margin assumptions lower, with adjusted earnings now expected nearer the bottom of the unchanged range.
Victor Sage
Victor Sage
3 Nov 2026
Holista Colltech reported positive adjusted operating cash flow of A$318,000 for the September quarter, although statutory cash flow remained negative after its final ProImmune settlement payment. The company also pushed the planned start of its Collie collagen plant from December 2026 to May-July 2027, while ending the quarter with just A$23,000 in cash.
Victor Sage
Victor Sage
30 Oct 2026
Anagenics says restructuring has reduced quarterly operating cash outflows to A$10,000 and put the business into profitable trading. The company ended September with A$532,000 in cash, while A$377,000 of newly invoiced royalty revenue was still to be received.
Victor Sage
Victor Sage
22 Oct 2026
Elixinol Wellness lifted Q3 gross profit 27% and delivered a fourth consecutive quarter of positive underlying operating cash flow, despite statutory operating cash flow remaining negative and cash below A$1 million. The proposed all-scrip Vitable acquisition could add scale, but shareholder approval and a thin liquidity buffer remain important next tests.
Victor Sage
Victor Sage
14 Oct 2026
OMG Group has reported its first positive quarterly EBITDA, with preliminary Q1 FY27 net sales rising 59% to approximately $1.92 million. The result marks a potential inflection point for the health and wellness food company, although the figures remain unaudited and do not establish cash profitability.
Victor Sage
Victor Sage
1 Oct 2026
Elixinol Wellness will acquire personalised supplement platform Vitable for headline consideration of A$2.5 million in shares, adding recurring revenue and more than 7,850 active subscribers. The deal could lift combined revenue to A$27 million by 2028, but remains subject to shareholder approval and carries meaningful dilution risk.
Victor Sage
Victor Sage
24 Sept 2026
Elixinol Wellness has finalized the divestment of its US operations to Ananda Health, securing upfront and deferred payments totaling approximately A$465,000. This move refocuses the company on its Australian health and wellness portfolio while reducing exposure to US regulatory risks.
Victor Sage
Victor Sage
7 Sept 2026
Thrive Tribe Technologies (ASX:1TT) has secured $500,000 through a placement of 500 million shares at $0.001 each, aiming to support general working capital and cover placement costs.
Sophie Babbage
Sophie Babbage
3 Sept 2026
Me Today Limited delivered a 36% revenue surge to $7.96 million in FY26, cutting its EBITDA loss by 43% and locking in $1.59 million of new capital from major shareholders ahead of October warrant exercises.
Victor Sage
Victor Sage
27 Aug 2026
Future Generation Global's half-year profit fell sharply as its portfolio lagged global benchmarks, yet it boosted its fully franked interim dividend reflecting confidence in its income sustainability.
Claire Turing
Claire Turing
26 Aug 2026
Bega Cheese Limited has delivered a robust FY2026 with a $54.8 million statutory profit, a 6.7% revenue increase, and a raised final dividend of 7.5 cents per share. The company is advancing its strategic growth plans focused on high-protein products, international expansion, and sustainability initiatives.
Victor Sage
Victor Sage
20 Aug 2026

Browse the archive

Full archive